Chardan Analyst: Gene Therapy Stocks Start their Long Ride to the Upside
Chardan Analyst Geulah Livshits, PhD, picks the top gene therapy stocks to buy for investors for 2021 and beyond.
Elaine Fuchs Geulah Livshits Brandeis University Senior Research Analyst At Chardan Rockefeller University Senior Research Analyst
Source: twst.com